The Kidney Transplant is to treat end-stage renal illness is known as a kidney transplant or renal transplant (ESRD). Kidney transplantation can be characterised as either living or deceased donor transplantation depending on the donor. Because kidney transplants improved ESRD patients' outcomes, they became very popular. The FDA granted Sanofi's Thymoglobulin, which is intended to prevent acute kidney transplant rejection, approval in April 2017. The most frequent type of transplant surgery worldwide is kidney transplantation. It has received much praise for significantly bettering the prognoses of patients with end-stage renal illness (ESRD).
According to a study conducted by experts, these 493 kidneys had survival rates of 93% after one year, 83% after five years, and 68% after ten years. This is because many donor kidneys in the United States are thrown unnecessarily.
Major players operating in the global Kidney Transplant Market include Sanofi, Pfizer, Inc., Novartis AG., B. Braun Melsungen AG, Fresenius Medical Care, Medtronic, Preservation Solution Inc., TransMedics, Inc., Organ Recovery Systems, and Transonic Systems Inc.
The most recent epidemic was the coronavirus (COVID-19) pandemic, which was first identified on December 31, 2019, in Wuhan, China. Global supply, distribution, and manufacturing of medical goods were all hampered by the shutdown. Additionally, the number of people visiting hospitals and clinics has decreased by more than 70% as a result of social isolation during this pandemic. This has reduced the number of operations, clinical trials, research and development projects, and other activities, which has hurt the market's expansion.
Segments covered:
By Type: Living Donor Transplant, Paired Kidney Transplant, Deceased Donor Transplant
By Age: Children, Adults
By End Users: Hospitals & Clinics, Transplant Centers
Read More- https://cmi-latestreportorientedblogs.blogspot.com/2023/03/kidney-transplant-market-size-share.html
